Many attempts have been made to discover a metabolic difference' between corresponding normal and neoplastic tissues of an individual. The reasons for such efforts are clear. If a specific metabolic reaction could be found to take place in malignant tissues, and not to occur in the corresponding normal structures, a definite point of departure would be available for a more precise study of the nature of the disease, and also possibly for the control of it. A qualitative metabolic difference, if it were found to occur, would make possible a more concise biochemical definition of the neoplastic tissue, but even a quantitative difference in the extent of some isolated reaction, if it were to be established securely, might prove to be a considerable advance in knowledge, even though the qualitative difference would probably be the most useful. Therefore any evidence which would indicate a difference in some specific metabolic reaction, or connected set of reactions, is noteworthy.
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In previous papers2-5 it has been shown that selectively acting antimetabolites can be realized which have a predictable ability to harm one kind of living thing, and to leave others untouched. This selectivity has been viewed as a prime requisite of successful chemotherapeutic agents. The preceding work has indicated that one of the ways in which such discriminatory action can be achieved is to choose a precursor of metabolites concerned in the intimate processes of cell division, and to make structural analogs of this precursor. Such antimetabolites will then damage those kinds of cells which conduct the synthesis of the vitamins (or other vital metabolites) from the aforementioned precursor, but will not touch those cells which do not. These latter kinds of cells can be distinguished readily from the former because they show their inability to conduct the synthesis of the vitamins by requiring them as essential constituents of their food. Thus, by knowing the dietary requirements of living things for certain compounds important in processes of cell division, and by knowing the precursors from which these are made in some organisms, it is possible to construct antimetabolites with a predictable selective action.
In order to achieve selectively acting agents which will function in a mixed population, a further refinement must be made.4' 5 This is to choose a precursor which is common to the synthesis of two or more of the vitamins.
In the cases examined this seemed necessary as one way to avoid the nullification of the antimetabolite effect by the vitamins themselves.
The particular example most studied involved riboflavin and vitamin B12 as the vitamins, and dimethyldiaminobenzene as the common precursor of them. Analogs of this precursor, such as dichlorodiaminobenzene and several others,6 inhibited the growth of those micro-organisms and higher forms which manufactured their own riboflavin and vitamin B12, but left unharmned those species which showed a dietary need for these vitamins.
Higher animals, such as mice, were among the vitamin-requiring species, and they were not harmed detectably by the antimetabolites.
If, now, the neoplasms which affect mammals were to be found capable of synthesizing their own supplies of riboflavin and of vitamin B12, one would expect that these tissues, like other living things so constituted with respect to these vitamins, would be susceptible to the action of these antimetabolites, whereas the animal as a whole would not be. A clear basis for chemotherapeutic attack would thus emerge.7 The purpose of this paper is to present evidence that the spontaneous mammary cancers of mice synthesize vitamin B12.
The proper way to determine the nutritional needs of cancers would be to grow them by themselves, free of normal tissue, in a culture fluid of known chemical constitution. At Demonstration of Storage of Vitamin B12 by the Mothers.-Mice were handled as described in the preceding section, except that the parents were supplied the supplemented ration (10 y vitamin B12 per 100 g. of ration) up to the time of parturition. They were then given the deficient ration, and, following weaning, the growth rate of the young was determined while they were being fed the deficient diet. From the data of table 2 it is clear that such young mice grew at a rate only slightly less than that of those which were constantly supplied with more than adequate amounts of the vitamin. During gestation, it was concluded, enough vitamin B12 was stored by the mother, and passed on to the embryonic young, to suffice for the rearing of these young. One of these groups was examined in May and the other in January. The remaining data were collected in January. These spontaneous mammary cancers were particularly suited for the present work, because, although they were transplantable and otherwise gave clear evidence of malignancy'3 (e.g., they invariably killed their hosts), they progressed slowly. Thus, most mice carrying a tumor at least 1 X 1 X 0.5 cm. would conceive, bear litter, and wean it before the tumor had become open and necrotic, and before the animal became moribund. This was of importance to the present experiments for obvious reasons. If one is to depend on the growth rate of young animals for one's conclusions, these young must come from mothers which are well enough to nurse a litter adequately. Furthermore, because some micro-organisms are known to synthesize vitamin B12, the growth of such organisms in a necrotic tumor could seriously complicate the interpretation of results. Consequently, in the following experiments, animals from mothers which were exceedingly ill, or which had tumors that had opened, were avoided.'4 The taking of these precautions, and even more, the low fecundity of cancerous females, made the procurement of adequate numbers of animals a most difficult task.
Groups of 3 females, each bearing a spontaneous mammary tumor at least 1 cm. long, 1 cm. wide, and 0.5 cm. high, were caged with a normal male of proved fertility, and fed the deficient ration. The same precautions were observed as in the case of the first experiments (those with noncancerous animals) described in this paper. Table 4 shows the growth rates of the weanlings from these tumorous mothers. It is evident that they grew considerably more rapidly than did those from non-tumorous mothers, and approached the gains of those from nonnal mothers which had received the B12-supplemented diet during gestation (cf. table 2).
The greater rate of gain of mice from tumor-bearing mothers could have been due to an innate difference of these from the normals, without respect to vitamin B12. This question was examined in the following way. A group,of weanlings from tumorous mothers, which had been kept on the deficienit diet, was fed the supplemented ration during the period when their growth-performance was measured. If there had been an innate constitutional difference of these from the normals which made them grow faster, then they should have gained more than did similarly supplemented weanlings from non-tumorous mothers. Actually, however, the two groups gained weight at approximately the same rate (5.4 g. per week for the ones from tumorous mothers, and 5.1 g. per week for those from normal mothers). group of young was obtained from females treated exactly as described except that no transplantation was carried out. The average rate of growth of young from the tumor-bearing mothers was 3.2 g., and that for those from the normal mothers was 3.3 g. (compare table 5 ). Trials With Urethane-Induced Lung Adenomas.-A large number (one hundred) of Swiss females 6 weeks of age were given urethane, 2 g. per kilo, in a single intraperitoneal dose. Four months later, autopsy of 12 of these animals showed that the nodules in the lungs were present in all (average number 37, range 7-54), and that they were quite large as such lesions go. Six of the surviving animals were then fed the deficient ration, and a week later, males were introduced to them. The experiment was then conducted as described for mice with spontaneous mammary cancers. Two experiments were performed. In the first, the average gain per week of the young was 3.8 g., and in the second it was 4.0 g. The presence of relatively large nodules in the lungs of the mothers was established by autopsy shortly after the litters were weaned.
Although these data indicated that no significant synthesis of vitamin B12 could be attributed to these adenomas, there was still some doubt about it. The females bearing the urethane-induced tumors did not prove to be very fecund, and frequently ate their young during the suckling period. In several litters the individuals were all noticeably undersized at 21 days of age. In order to obtain weanlings large enough to survive when placed on the deficient ration in individual cages, the time of weaning had to be prolonged to 23 or 24 days (cf. Ref. 14). These considerations, taken along with the fact that the average rate of gain was slightly above the values of table 1 in both experiments, may indicate that some synthesis of vitamin B12 was conducted by the adenomas.
DISCUSSION
If the present evidence is accepted as showing that spontaneous mammary tumors synthesize large amounts of vitamin B12, it would constitute the first demonstration of a qualitative metabolic difference between normal and neoplastic tissue, and would likewise point directly to a rational pathway of chemotherapeutic attack. Let us therefore attempt to see whether some other explanation can be attached to the observed facts. The data presented seem adequate to show that mice bom and raised on a diet deficient in vitamin B12 grew faster if their mothers carried spontaneous mammary tumors. Furthermore, such mice grew almost as fast as similar individuals, the mothers of which had received this vitamin in their food, and two-thirds as fast as mice given continuously a superabundant supply of B12.
It may be that the apparent synthesis of the vitamin was due to growth of B12-forming micro-organisms in necrotic portions of the cancers. This possibility was constantly held in mind, and because of it seemingly uninfected growths only were used. It may also be that necrosis of the older portions of the tumor was occurring with the liberation of vitamin B12 into the circulation of the animals. This possibility cannot be excluded. Nevertheless, the failure of transplanted mammary tumors to give evidence of vitamin synthesis would seem to be a control of this unknown because the necrosis in the transplant should have been at least as much as that in the spontaneous cancers. The same argument might also apply against the idea that the vitamin arose from microbial action.
It may be that normal mammary tissue carried out the synthesis of vitamin B12, but, because it represented only a small portion of the total weight of the animal, the amount formed was not sufficient to meet all needs. When the cancer arose the proportion of this kind of tissue would be greatly increased, and might thus suffice to meet the demand for B12. The B12-manufacturing facilities of the mouse would thus merely be increased incidentally with the propagation of cells derived from mammary tissue. This also is a possibility which cannot be excluded, because it is not possible to grow mammary tissues in a chemically defined medium, and to measure any synthesis of the vitamin. There is no evidence to show that a normal mouse cannot form small amounts of vitamin B12. All that preceding nutritional investigations have revealed is that such an animal cannot make enough of it to sustain normal function, and, in some cases, life itself. However, in consideration of this possibility for explanation of the facts observed in the present work, the failure of the transplanted mammary cancers to show evidence of B12 synthesis would seem to argue in favor of the alternative hypothesis which is the thesis of this paper. Nevertheless, because of the limited trials with transplanted tumors in the present work, it would be unjustifiable to emphasize unduly the failure of such transplants to give evidence of vitamin B12 synthesis. More If it be concluded that the spontaneous cancers differ from normal tissue in possession of the ability to synthesize vitamin B12, then the kinship of this phenomenon to some findings in the plant kingdom is striking enough to warrant consideration."7 Thus, Gautheret'8 has found that the crown galls of plants differ from the corresponding normal tissue in being able to synthesize the growth hormone indole acetic acid. . The normal tissue grew in a synthetic medium only when the hormone was added, whereas the cells from the galls grew well without it and, in fact, produced it. A second instance is that reported by Steward and Caplinlg during the progress of the work described in the present paper. They observed that while carrot tissue could be cultivated in vitro in a synthetic medium, this was true only if the inoculum contained cambium cells. When care was taken to exclude cambium from the transplant, very little growth took place until an unknown substance present in coconut milk was added. Thus, the cambium could make its own supply of this coconut milk factor, whereas other cells of the carrot root could not. 12 Although one may ask whether the cages were changed often enough, the data of tables 1-4 will indicate that they were. If they had not been, it probably would not have been possible to demonstrate the difference in rate of growth between deficient and supplemented animals.
1I Through the courtesy of Dr. H. B. Andervont of the National Cancer Institute, biopsy specimens from a number of these animals were examined histologically and were pronounced to be mammary adenocarcinomas.
14 The ability of the mothers to nurse their young adequately was reflected in the condition of these young at weaning time (21 days). In the experiments to be described, care was taken to use those litters in which the young were all of approximately the same size as those from normal deficient mothers. Occasionally, litters were encountered in which the young were smaller than this at 21 days and in fact were still being nursed by their mothers. In these instances the tumors of the mothers wqre unusually large, e.g., 4 X 3.5 X 2.5 cm. in one of the cases. In such instances, the weaning of the young was delayed for two or even three days. Experience with such litters showed that when placed on a vitamin B12-deficient ration the rate of gain was usually less than that seen with robust litters. Nevertheless, the average rates of gain shown in table 4 included the values obtained from two of these litters which had been weaned late and had grown less rapidly.
15 C3H mice bearing spontaneous mammary tumors were purchased from the Jackson Memorial Laboratories. The C strain animals were very generously supplied by Dr. E. S. Rogers of the Rockefeller Institute. 16 The author is well aware that there is no experimental proof that transplants differ from spontaneous tumors. Nevertheless, he is also aware that many shreds of evidence have led a considerable number of experienced investigators to the view that there actually may be a difference. Perhaps the facts presented in this paper may be construed as tangible evidence in this direction. 17 After the completion of this manuscript the author's attention was called to a paper by J. Lederberg (Science, 104, 428 (1946)) in which the suggestion was made that a back mutant of a "leucineless" fungus, Neurospora crassa, was comparable to mammalian cancer, whereas the "leucineless" strain itself was comparable to normal mammalian tissue. If this view is valid, then the "malignant" mutant differed from the "normal" in possession of a leucine-synthesizing capacity.
18 Gautheret, R. J., Endeavour, 9, 21 (1950 
